In Silico Study of Bioactive Compounds from Syzygium malaccense Targeting HER2 and Progesterone Receptors in Breast Cancer
Abstract
Breast cancer remains one of the most common causes of cancer-related deaths among women, with progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) being key molecular targets in its progression. This study aimed to explore the potential of bioactive compounds from Syzygium malaccense that have exhibited anticancer activities, as targeted inhibitors for PR and HER2, using computational approaches. A total of 155 compounds were initially screened for anticancer potential using the Prediction of Activity Spectra for Substances (PASS), identifying 80 compounds for further analysis. Drug-likeness and pharmacokinetic predictions indicated that several compounds complied with the Rule of Five (RO5) and had favorable absorption and distribution profiles, suggesting their suitability as oral drug candidates. Molecular docking revealed that quercetin exhibited favorable interactions with PR, particularly involving the ARG 766 residue, while myricetin demonstrated strong binding affinity to HER2, surpassing trastuzumab, and interacting with key residues Asp 863, Lys 753, Ala 751, and Leu 796. Molecular dynamics simulations confirmed the stability of the Myricetin-HER2 complex under physiological conditions over 15 ns, supporting its potential as a HER2 inhibitor. These findings highlight myricetin and quercetin as promising natural compounds for breast cancer therapy targeting HER2 and PR, respectively. However, further experimental validation, including in vitro and in vivo studies, is necessary to confirm their therapeutic efficacy and safety. Overall, this study supports Syzygium malaccense as a valuable source of natural bioactive compounds for breast cancer drug discovery.
Keywords: in silico screening, Syzygium malaccense, breast cancer, progesterone receptor, HER2.
Full Text:
PDFReferences
Altundag, E., Becer, E., Gencalp, D., and Vatansever, S., 2020, The Investigation of Antiproliferative Effects of Quercetin, Curcumin and their Combinations on Breast Cancer Cell Lines, Ankara Üniversitesi Eczacılık Fakültesi Dergisi, 44(3), 424-436.
Amalia, E., Diantini, A., and Subarnas, A., 2019, Overview of current and future targets of breast cancer medicines, Journal of Pharmaceutical Sciences and Research, 11(6), 2385–2397.
Arumugam, B., Palanisamy, U.D., Chua, K.H., and Kuppusamy, U.R., 2019, Protective effect of myricetin derivatives from Syzygium malaccense against hydrogen peroxide-induced stress in ARPE-19 cells, Molecular Vision, 25, 47–59.
Astuty, P., and Komari, N., 2022, Kajian Molecular Docking Senyawa Karwinaphthol B dari Tanaman Bawang Dayak (Eleutherine palmifolia (L.) Merr) sebagai Inhibitor Enzim Glukokinase, Jurnal Natural Scientiae, 2(1), 01-09.
Batista, Â.G., da Silva, J.K., Cazarin, C.B.B., Biasoto, A.C.T., Sawaya, A.C.H.F., Prado, M.A., and Júnior, M.R.M., 2017, Red-jambo (Syzygium malaccense): Bioactive compounds in fruits and leaves, LWT-Food Science and Technology, 76(Part B), 284–291.
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., and emal, A., 2024, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians, 74(3), 229–263.
Chairunisa, F., Safithri, M., Andrianto, D., Kurniasih, R., and Irsal, R.A.P., 2023, Molecular Docking of Red Betel Leaf Bioactive Compounds (Piper crocatum) as Lipoxygenase Inhibitor, Indonesian Journal of Pharmaceutical Science and Technology, 10(2), 90–103.
Doak, B.C., Over, B., Giordanetto, F., and Kihlberg, J., 2014, Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates, Chemistry & Biology, 21(9), 1115– 1142.
Dulsat, J., López-Nieto, B., Estrada-Tejedor, R.,and Borrell, J.I., 2023, Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments, Molecules, 28, 776.
Eastman, P., Swails, J., Chodera, J.D., McGibbon, R.T., Zhao, Y., Beauchamp, K.A., et al., 2017, OpenMM 7: Rapid development of high performance algorithms for molecular dynamics, PLoS Computational Biology, 13(7), e1005659.
Feltrin, F.M., Gibbert, L., Santos, N.C.S., Marques, F.A., Miguel, M.D., Zanin, S.M.W., et al., 2020, Extraction and identification of essential oil components from the leaves of Syzygium malaccense (L.) MERR. & L.M. PERRY, MYRTACEAE, Ciência e Natura, 42, e6.
Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V, Druzhilovskii, D.S., Pogodin, P.V., and Poroikov, V.V., 2014, Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource, Chemistry of Heterocyclic Compounds, 50, 444–457.
Hartanti, I.R., Putri, A.A., AS, N.N.A., Triadenda, A.L., Laelasari, E., Suhandi, C., and Muchtaridi, 2022, Molecular Docking Senyawa Xanton, Benzofenon, dan Triterpenoid Sebagai Antidiabetes dari Ekstrak Tumbuhan Garcinia Cowa, Jurnal Kimia, 16(1), 72–83.
Hsu, J.L., and Hung, M.-C., 2016, The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer, Cancer Metastasis Reviews, 35(4), 575–588.
Ismail, I.S., Ismail, N., and Lajis, Md.N., 2010, Ichthyotoxic properties and essential oils of syzygium malaccense (Myrtaceae), Pertanika Journal of Science and Technology, 18(1), 1–6.
Jayaram, B., Singh, T., Mukherjee, G., Mathur, A., Shekhar, S., and Shekhar, V., 2012, Sanjeevini: a freely accessible web-server for target directed lead molecule discovery, BMC Bioinformatics, 13, S7.
Karioti, A., Skaltsa, H., and Gbolade, A.A., 2007, Analysis of the leaf oil of Syzygium malaccense merr. et perry from Nigeria, Journal of Essential Oil Research, 19(4), 313–315.
Lu, Z., Wang, T., Wang, L., and Ming, J., 2025, Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer, Translational Oncology, 56, 102387.
Mokashi, A., and Bhatia, N.M., 2024, Integrated Network Ethnopharmacology, Molecular Docking, and ADMET Analysis Strategy for Exploring the Anti-Breast Cancer Activity of Ayurvedic Botanicals Targeting the Progesterone Receptor, BIO Integration, 5(1), 1–17.
Mutiah, R., Dewi, T.J.D., Suryadinata, A., and Qonita, K., 2021, Inhibition of Human Epidermal Growth Factor Receptor-2 (HER-2) from Pomelo (Citrus maxima) Flavonoid Compounds: an In Silico Approach, Indonesian Journal of Cancer Chemoprevention, 12(3), 148-160.
Nunes, P.C., de Souza Aquino, J., Rockenbach, I.I., and Stamford, T.L.M., 2016, Physico-chemical characterization, bioactive compounds and antioxidant activity of Malay apple [Syzygium malaccense (L.) Merr. & L.M. Perry], PLoS ONE, 11(6), 1–11.
Nusantoro, Y.R., and Fadlan, A., 2020, Analisis sifat mirip obat, prediksi ADMET, dan penambatan molekular isatinil-2-aminobenzoilhidrazon dan kompleks logam transisi Co (II), Ni (II), Cu (II), Zn (II) Terhadap BCL2-XL, Akta Kimia Indonesia, 5(2), 114–126.
Oldoni, T.L.C., da Silva, C., Bicas, T.C., Ayres, B.R.B., Zanchet, E.R., Marafon, F., et al., 2025, Antihyperglycemic activity and bioguided isolation of phenolic compounds with antioxidant and cytotoxic properties from Syzygium malaccense leaves, Fitoterapia, 181, 106357.
Pino, J.A., Marbot, R., Rosado, A., and Vázquez, C., 2004, Volatile constituents of Malay rose apple [Syzygium malaccense (L.) Merr. & Perry], Flavour and Fragrance Journal, 19(1), 32–35.
Prasetiawati, R., Fauzan, N., and Suherman, M., 2023, In silico study: secondary metabolites from malay apple (Syzygium malaccense (L.) Merr. & L.M. Perry) as potential breast cancer treatments, Pharmaciana, 13(3), 268.
Prasniewski, A., da Silva, C., Ayres, B.R.B., da Silva, E.A., Pilau, E.J., Nani, B.D., et al., 2021, Characterization of phenolic compounds by UHPLC-QTOF-MS/MS and functional properties of Syzygium malaccense leaves, South African Journal of Botany, 139, 418–426.
Rajan, N.S., and Bhat, R., 2019, Bioactive Compounds of Plum Mango (Bouea Microphylla Griffith). In: Murthy, H., Bapat, V. (eds) Bioactive Compounds in Underutilized Fruits and Nuts. Reference Series in Phytochemistry. Springer, Cham.
Reis, A.S., Silva, L.de.S., Martins, C.F., and de Paula, J.R., 2021, Analysis of the volatile oils from three species of the gender Syzygium, Research, Society and Development, 10(7), e13510716375.
Sagitasa, S., Elizabeth, K., Sulaeman, L.I., Rafashafly, A., Syafra, D.W., Kristande, A., and Muchtaridi, 2021, Studi In Silico Senyawa Aktif Daun Singawalang (Petiveria alliacea) Sebagai Penurun Kadar Glukosa Darah Untuk Pengobatan Penyakit Diabetes Melitus Tipe-2, Chimica et Natura Acta, 9(2), 58–66.
Savi, A., Calegari, M.A., Calegari, G.C., Santos, V.A. Q., Wermuth, D., da Cunha, M.A.A., and Oldoni, T.L.C., 2020, Bioactive compounds from syzygium malaccense leaves: Optimization of the extraction process, biological and chemical characterization, Acta Scientiarum Technology, 42, e46773.
Suherman, M., Prasetiawati, R., and Ramdani, D., 2020, Skrining Virtual Senyawa Aktif Asam Jawa (Tamarindus indica L .) Terhadap Selektif Inhibitor Siklooksigenase-2, Jurnal Ilmiah Farmako Bahari, 11(2), 125–136.
Swain, S.M., Shastry, M., and Hamilton, E., 2023, Targeting HER2-positive breast cancer: advances and future directions, Nature Reviews Drug Discovery, 22(2), 101–126.
Tukiran, and Putri, D.O., 2021, Chemical profile by lc-ms analysis from the selected fraction of methanol extract of syzygium malaccense, Rasayan Journal of Chemistry, 14(1), 295–305.
Vadu, S., Modi, N., and Prajapati, M., 2023, a Review on Phytochemistry and Traditional Therapeutic Benefits of Syzygium Malaccense (L.), International Association of Biologicals and Computational Digest, 2(1), 275–286.
Yersal, O., and Barutca, S., 2014, Biological subtypes of breast cancer: Prognostic and therapeutic implications, World Journal of Clinical Oncology, 5(3), 412–424.
Zhao, J., Zhou, Z., Saw, P.E., and Song, E., 2025, Silver Jubilee of HER2 targeting: a clinical success in breast cancer, Journal of the National Cancer Center, 5(4), 371-391.
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev16iss1pp1-14
Copyright (c) 2025 Nawadhir Fauzan, Riska Prasetiawati, Meilia Suherman, Dhania Novitasari, Muchtaridi Muchtaridi
Indexed by:
Indonesian Society for Cancer Chemoprevention
